Related Experiment Video
Updated: Feb 28, 2026
Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
Published on: February 3, 2017
Angiogenic peptide nanofibers repair cardiac tissue defect after myocardial infarction
Abdul Jalil Rufaihah1, I Ceren Yasa2, Vaibavi Srirangam Ramanujam1
1Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Insights
Synthetic peptide nanofibers promote heart repair after myocardial infarction by stimulating new blood vessel growth without stem cells or growth factors. This innovative approach offers a promising new strategy for cardiovascular regeneration and improved cardiac function.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Cardiovascular Biology
Background:
- Myocardial infarction (MI) is a leading cause of death, often leading to heart failure due to limited cardiac regeneration.
- Current therapies for MI-induced damage face limitations, including risks associated with stem cells and growth factors.
- There is a critical need for innovative strategies to repair damaged myocardium and improve cardiac function post-MI.
Purpose of the Study:
- To investigate the efficacy of synthetic glycosaminoglycan (GAG) mimetic peptide nanofiber scaffolds in promoting cardiovascular repair after myocardial infarction.
- To evaluate the potential of these nanofibers to induce neovascularization and improve cardiac performance without biologically derived factors.
- To establish a novel, safe, and effective therapeutic approach for myocardial regeneration.
Main Methods:
- Development of synthetic GAG mimetic peptide nanofiber scaffolds.
- Injection of nanofiber gels into the infarct site of a rodent myocardial infarct model.
- Assessment of neovascularization, vascular cell recruitment, VEGF-A expression, and cardiac performance.
Main Results:
- Synthetic GAG mimetic peptide nanofibers significantly induced neovascularization in cardiovascular tissue post-MI.
- Increased vascular endothelial growth factor A (VEGF-A) expression and vascular cell recruitment were observed.
- Improved cardiac performance was demonstrated in the treated group compared to controls, without teratoma formation.
Conclusions:
- Synthetic GAG mimetic peptide nanofibers represent a groundbreaking therapeutic strategy for cardiovascular repair after myocardial infarction.
- This approach enhances cardiac function and promotes tissue regeneration without the need for stem cells or growth factors.
- These bioactive peptide nanofibers hold significant potential for future clinical applications in treating heart damage.
Abstract:
Myocardial infarction remains one of the top leading causes of death in the world and the damage sustained in the heart eventually develops into heart failure. Limited conventional treatment options due to the inability of the myocardium to regenerate after injury and shortage of organ donors require the development of alternative therapies to repair the damaged myocardium. Current efforts in repairing damage after myocardial infarction concentrates on using biologically derived molecules such as growth factors or stem cells, which carry risks of serious side effects including the formation of teratomas. Here, we demonstrate that synthetic glycosaminoglycan (GAG) mimetic peptide nanofiber scaffolds induce neovascularization in cardiovascular tissue after myocardial infarction, without the addition of any biologically derived factors or stem cells. When the GAG mimetic nanofiber gels were injected in the infarct site of rodent myocardial infarct model, increased VEGF-A expression and recruitment of vascular cells was observed. This was accompanied with significant degree of neovascularization and better cardiac performance when compared to the control saline group. The results demonstrate the potential of future clinical applications of these bioactive peptide nanofibers as a promising strategy for cardiovascular repair.
Statement Of Significance:
We present a synthetic bioactive peptide nanofiber system can enhance cardiac function and enhance cardiovascular regeneration after myocardial infarction (MI) without the addition of growth factors, stem cells or other biologically derived molecules. Current state of the art in cardiac repair after MI utilize at least one of the above mentioned biologically derived molecules, thus our approach is ground-breaking for cardiovascular therapy after MI. In this work, we showed that synthetic glycosaminoglycan (GAG) mimetic peptide nanofiber scaffolds induce neovascularization and cardiomyocyte differentiation for the regeneration of cardiovascular tissue after myocardial infarction in a rat infarct model. When the peptide nanofiber gels were injected in infarct site at rodent myocardial infarct model, recruitment of vascular cells was observed, neovascularization was significantly induced and cardiac performance was improved. These results demonstrate the potential of future clinical applications of these bioactive peptide nanofibers as a promising strategy for cardiovascular repair.
